Author Archives: Margarida Maia

New R&D Center Will Focus on Cell-based Therapies

Biopharmaceutical company Brooklyn ImmunoTherapeutics has launched a new center focused on research and development (R&D) of gene editing and cell-based therapies to treat cancer and rare blood disorders, including sickle cell disease. “Our new R&D facility will provide us with the ability to advance our research and development…